Cynosure’s Accolade(TM) Workstation For Pigmented Lesions Receives Korean Regulatory Approval
Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, announced that it has received market approval from the Korea Food & Drug Administration (KFDA) for its flagship Accolade(TM) workstation for the removal of pigmented lesions.
This post is an original post by ScienceDaily: Skin Care News
Posted: May 8th, 2008 under skin health.
Comments: none
Write a comment